1000 resultados para Experimental leishmaniasis
Resumo:
Diagnostic and parasite characterization and identification studies were carried out in human patients with cutaneous leishmaniasis lesions in Santiago del Estero, Northern Province of Argentina. Diagnostic procedures were biopsies of lesions for smears and inoculations in hamster, needle aspirations of material from ulcers for "in vitro" cultures. Immunodiagnostic techniques applied were IFAT-IgG and Montenegro skin test. Primary isolation of eight stocks of leishmanial parasites was achieved from patients with active lesions. All stocks were biologically characterized by their behaviour in hamster, measurements of amastigote and promastigotes and growth "in vitro". Eight stocks were characterized and identified at species level by their reactivity to a cross-panel of sub-genus and specie-specific Monoclonal Antibodies through an Indirect Immunofluorescence technique and a Dot-ELISA. We conclude from the serodeme analysis of Argentina stocks that: stocks MHOM/AR/92/SE-1; SE-2; SE-4; SE-8; SE-8-I; SE-30; SE-34 and SE-36 are Leishmania (Viannia) braziliensis. Three Leishmania stocks (SE-1; SE-2 and SE-30) did not react with one highly specie-specific Monoclonal Antibody (Clone: B-18, Leishmania (Viannia) braziliensis marker) disclosing two serodeme group patterns. Five out of eight soluble extracts of leishmanial promastigotes were electrophoresed on thin-layer starch gels and examined for the enzyme MPI, Mannose Phosphate Isomerase; MDH, Malate Dehydrogenase; 6PGD, 6 Phosphogluconate Dehydrogenase; NH, Nucleoside Hydrolase, 2-deoxyinosinc as substrate; SOD, Superoxide Dismutase; GPI, Glucose Phosphate Isomerase and ES, Esterase. From the isoenzyme studies we concluded that stocks: MHOM/AR/92/SE-1; SE-2; SE-4; SE-8 and SE-8-I are isoenzymatically Leishmania (Viannia) braziliensis. We need to analyze more enzymes before assigning them to a braziliensis zymodeme.
Resumo:
Immunosuppressed animals respond poorly to schistosomal chemotherapy and that a proper response can be restored by the administration of immune serum. Present study attempts to search whether immunological stimulation would increase drug effectiveness. Swiss mice infected with 50 S. mansoni cercariae were later treated with complete Freund's adjuvant. Treatment with oxaminiquine was made with 100 mg/kg.b.w., 25 mg/kg.b.w. and 50 mg/kg/b.w., the last two doses representing a fourth and a half of the recommended curative dose. Appropriate controls for the drug, the adjuvant and the infection were also studied. The serum-level of ant-S. mansoni antibodies (ELISA) and recovery of worms by perfusion of the portal vein system were the evaluated parameters. Statistical analysis of the results failed to reveal significant differences in worm recovery between adjuvant-stimulated animals treated with oxamniquine and any of the treated controls receiving the same amount of the drug. Although total lack of immunity interferes with curative treament the usual immune response seems to be sufficient to allow for curative drug action in schistosomiasis and thus apparently does not need to be artificially stimulated
Resumo:
Dissertação para a obtenção do Grau de Mestre em Mestrado Integrado em Engenharia Civil - Perfil de Construção
Resumo:
Dissertação apresentada para obtenção do grau de Mestre em Engenharia Civil
Resumo:
Trabalho apresentado no âmbito do Mestrado em Engenharia Informática, como requisito parcial para obtenção do grau de Mestre em Engenharia Informática.
Resumo:
Dissertação apresentada para obtenção do Grau académico de Mestre em Engenharia Civil, na especialidade de Reabilitação de Edifícios, pela Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa
Resumo:
Rehabilitation is becoming more and more usual in the construction sector in Portugal. The introduction of newer construction materials and technical know-how of integrating different materials for achieving desired engineering goals is an important step to the development of the sector. Wood industry is also getting more and more adapted to composite technologies with the introduction of the so called “highly engineered wood products” and with the use of modification treatments. This work is an attempt to explain the viability of using stainless steel and glass fibre reinforced polymer (GFRP) as reinforcements in wood beams. This thesis specifically focuses on the flexural behaviour of Portuguese Pine unmodified and modified wood beams. Two types of modification were used: 1,3-dimethylol-4,5- dihydroxyethyleneurea (DMDHEU) resin and amid wax. The behaviour of the material was analysed with a nonlinear model. The latter model simulates the behaviour of the reinforced wood beams under flexural loading. Small-scale beams (1:15) were experimented in flexural bending and the experimental results obtained were compared with the analytical model results. The experiments confirm the viability of the reinforcing schemes and the working procedures. Experimental results showed fair agreement with the nonlinear model. A strength increase between 15% and 80% was achieved. Stiffness increased by 40% to 50% in beams reinforced with steel but no significant increase was achieved with the glass fibre reinforcement.
Resumo:
Dissertação apresentada na Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa para a obtenção do grau de Mestre em Engenharia Mecânica
Resumo:
Treatment of mucosal leishmaniasis (ML) can be controlled by clinical examination and by serologic titers by the indirect immunofluorescence serologic reaction (IISR). We studied the correlation between the presence of antigen in tissue determined by immunohistochemistry, the IISR titers and the anatomopathologic findings in fifteen patients with ML before and after healing of the lesions as determined by otorhinolaryngologic evaluation, and evaluated these parameters to determine which of them could be useful during follow-up. Tissue antigens became negative in four patients (group A) after treatment, with a statistically significant reduction or negativity of IISR titers (p<0.05). This did not occur in patients in whom the antigen persisted after treatment (group B), suggesting that serologic follow-up should be performed together with the search for tissue antigen, a combination which, to our knowledge, has not been used in previous studies. The negativity of tissue antigens and the behavior of IIRS titers in group A patients probably indicate a lower possibility of recurrence. Upon anatomopathologic examination the inflammatory process was found to persist after treatment even in group A, suggesting that the permanence of inflammatory activity even in clinically healed lesions is possibly correlated with the presence of the antigen or of some unknown factor.
Resumo:
A survey for canine tegumentary leishmaniasis (CTL) has been carried out between 1986 and 1993 in seven endemic localities for American cutaneous leishmaniasis in the State of Rio de Janeiro. 270 dogs have been examined for their clinical aspects, the development of delayed hypersensitivity (DHS) with Immunoleish antigen and with immunofluorescent antibody research of IgG (IF). 28.2% of them had ulcer lesions and 3.3% had scars. The lesions consisted of single (39.5%) and mucocutaneous lesions (31.6%), multiple cutaneous (25.0%) and mucocutaneous lesions associated with cutaneous ulcers (4.0%). Twelve (15.8%) isolates from biopsies were analyzed by zimodeme and schizodeme and identified as L. (V.) braziliensis. The overall prevalence of canine infection that was evaluated with the skin test was of 40.5% and with IF it was of 25.5%. Both tests showed a high positive rate with relation to the animals with mucosal lesions, as in the case of human mucocutaneous leishmaniasis. The comparison of the two tests showed the skin test to have a better performance although there was no statistical difference (p>0.05) between them. The proportional sensitivity and specificity was of 84.0% and 74.0%, respectively. The Immunoleish skin test and IF are useful tools to be employed in CTL field epidemiological surveys.
Resumo:
Dissertação de Mestrado em Engenharia Informática
Resumo:
Background: Pentavalent antimonials have became of basic importance for the treatment of leishmaniasis. Their most severe side effects have been reported to be increased hepatic enzyme levels and electrocardiographic abnormalities. Nephrotoxicity has been rarely related. Observations: We report a case of generalized cutaneous leishmaniasis involving a 50-year old male patient who was submitted to treatment with meglumine antimoniate (Glucantime). He developed acute renal failure (ARF) due to acute tubular necrosis (ATN), followed by death after receiving a total of 53 ampoules of Glucantime. Conclusions: The treatment with Glucantime was responsible by ARF diagnosed in this patient. The previous urine osmolarity and serum creatinine levels were normal and the autopsy showed ATN. It should be pointed out if ARF may also be explained by massive deposits of immunocomplexes by leishmania antibodies and antigens due to the antigenic break by the antimonial compound, since our patient presented countless lesions covering the entire tegument, similar to the Hexheimer phenomenon, but at the autopsy no glomerular alterations were seen.
Resumo:
Após o enquadramento da canoagem, como modalidade Olímpica, verificou-se um aumento significativo de estudos e pesquisas acerca da biomecânica da modalidade, o que contribuiu para uma diminuição dos tempos na competição. Contudo poucos foram os que se focaram nas forças desenvolvidas e aplicadas ao caiaque através do finca-pés, criado assim oportunidade de desenvolvimento de dispositivos para a medição das mesmas. Assim, o objectivo primordial é desenvolver um sistema experimental capaz de quantificar as forças geradas em cada um dos lados do finca-pés (esquerdo e direito). Este, deverá não só ser passível de se utilizar em caiaque ergómetro como também num caiaque de pista, permitido avaliar as forças aplicadas durante o ciclo de pagaiada, tanto em compressão como em tracção. A sua concepção baseou-se num modelo de finca-pés já existente, tornando-o compatível com os caiaques de competição mais comercializados, e permitindo que no futuro se possa utilizar na água, bastando para isso apenas possuir um caiaque e embarcar o sistema de medição. Este sistema experimental foi testado em caiaque ergómetro por 7 (sete) sujeitos com níveis distintos: seis homens (um atleta olímpico medalhado e cinco de nível nacional) e uma mulher (de nível de selecção Portuguesa) que, entre outros, realizaram um plano definido por 60s a uma frequência de 75 pagaiadas por minuto, seguido de uma intensa mudança de ritmo e força (Sprint). Após análise dos dados obtidos em cada um dos diferentes sujeitos, conseguimos identificar algumas das suas características, tais como: esforço assimétrico dos membros inferiores; utilização de forma heterogénea da fita do finca-pés; diferença de forças máximas aplicadas entre atletas (Ex.: para um atleta olímpico as forças medidas (Min; Max): Pé Esquerdo (- 444; 1087) N e Pé Direito (- 476; 1068) N); etc. Os resultados não só são bastante promissores como também são motivantes e congruentes com estudos anteriores, nomeadamente Begon et al. 2008 e Sturm 2010 e 2012. Finalmente, consegue-se afirmar, com segurança, que foram alcançados os objectivos propostos com a concepção deste dispositivo de medição de forças. Este permite caracterizar os esforços desenvolvidos no finca-pés por cada membro inferior, com ou sem a fita de suporte, possibilitando aos treinadores e atletas uma visão, para muitos desconhecida, das forças transmitidas e das suas assimetrias. No final, este conhecimento permitirá aos atletas melhorar o seu desempenho desportivo bem como facilitar a gestão desportiva, com base nos principais princípios mecânicos inerentes ao movimento dos atletas desde desporto Olímpico.
Resumo:
Trabalho apresentado no âmbito do Mestrado em Engenharia Informática, como requisito parcial para obtenção do grau de Mestre em Engenharia Informática.
Resumo:
Dissertação apresentada na Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa para obtenção do grau de mestre em Engenharia Biomédica.